Clinical trial
Levosimendan in High Risk Heart Valve Surgery
NCT00154115 · Kuopio University Hospital, Other · Completed
Key facts
| NCT number | NCT00154115 |
|---|---|
| Title | Levosimendan in High Risk Heart Valve Surgery |
| Official title | Efficacy of Levosimendan in Cardiac Failure After Heart Valve Surgery |
| Lead sponsor | Kuopio University Hospital, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Heart Failure |
| Intervention type | Drug |
| Interventions | levosimendan, placebo |
| Enrollment | 200 |
| Start date | Mar 1, 2005 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Sep 12, 2005 |
| Last update posted | Jan 21, 2009 |
| Countries | Finland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: